Incordex Corp. financial data

Symbol
ICDX on OTC
Location
6 Rosemary Way, Nuneaton, United Kingdom
State of incorporation
Nevada
Fiscal year end
June 30
Latest financial report
10-Q - Q1 2024 - May 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 109 %
Debt-to-equity 633 % +595%
Return On Equity 34 %
Return On Assets 4.64 %
Operating Margin 3.72 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.45M shares 0%
Common Stock, Shares, Outstanding 6.45M shares 0%
Entity Public Float 0 USD
Common Stock, Value, Issued 6.45K USD 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 35.9K USD
General and Administrative Expense 34.6K USD +197%
Operating Income (Loss) 1.33K USD
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent 1.33K USD

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.39K USD -43.6%
Assets, Current 9.15K USD -11.7%
Assets 32.2K USD +150%
Accounts Payable, Current 14K USD
Liabilities, Current 14K USD
Liabilities 25.3K USD +246%
Retained Earnings (Accumulated Deficit) -27.1K USD +4.69%
Stockholders' Equity Attributable to Parent 6.88K USD +24.1%
Liabilities and Equity 32.2K USD +150%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.89K USD -383%
Net Cash Provided by (Used in) Financing Activities 4K USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 6.45M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.8K USD -67.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Depreciation 416 USD 0%
Additional Paid in Capital 27.6K USD 0%
Depreciation, Depletion and Amortization 1.66K USD